DEF14A

Company

Emmaus Life Sciences, Inc.

Filed

October 6, 2015

Period of Report

October 28, 2015

Accession Number

0001615774-15-002846

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →